TRK inhibition in cholangiocarcinoma: Trying to teach an old dog new tricks by Alessandro Rizzo, Giovanni Brandi

Get full text

Asbestos and Intrahepatic Cholangiocarcinoma by Giovanni Brandi, Simona Tavolari

Get full text

Novel Targeted Therapies for Advanced Cholangiocarcinoma by Alessandro Rizzo, Giovanni Brandi

Get full text

IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience? by Giovanni Brandi, Alessandro Rizzo

Get full text

First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!” by Alessandro Rizzo, Giovanni Brandi

Get full text

Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review by Simona Tavolari, Giovanni Brandi

Get full text

Pace e guerra negli equilibri interpoleici del Mediterraneo antico by Giovanni Brandi Cordasco Salmena

Get full text

Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma by Alessandro Rizzo, Giovanni Brandi

Get full text

The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora’s box? by Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi

Get full text

Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma by Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi

Get full text

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer by Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi

Get full text

Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update by Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi

Get full text

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look by Angela Dalia Ricci, Alessandro Rizzo, Giovanni Brandi

Get full text

The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies? by Giovanni Brandi, Silvia Turroni, Florencia McAllister, Giorgio Frega

Get full text

Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue by Giovanni Brandi, Giovanni Brandi, Chiara Deiana, Chiara Deiana, Linda Galvani, Linda Galvani, Andrea Palloni, Angela Dalia Ricci, Alessandro Rizzo, Simona Tavolari, Simona Tavolari

Get full text

Improvements in Systemic Therapies for Advanced Malignant Mesothelioma by Chiara Deiana, Francesca Fabbri, Simona Tavolari, Andrea Palloni, Giovanni Brandi

Get full text

Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link by Giovanni Brandi, Kurt Straif, Daniele Mandrioli, Stefania Curti, Stefano Mattioli, Simona Tavolari

Get full text

Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma by Cristina Nanni, Cristina Mosconi, Valentino Dragonetti, Massimo Barakat, Nicola Fraccascia, Maria Adriana Cocozza, Stefano Brocchi, Andrea Palloni, Alexandro Paccapelo, Giovanni Brandi, Giovanni Brandi, Stefano Fanti, Stefano Fanti, Stefano Fanti

Get full text

Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-Analysis by Alessandro Rizzo, Angela Dalia Ricci, Annarita Fanizzi, Raffaella Massafra, Raffaele De Luca, Giovanni Brandi

Get full text

Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future by Alessandro Rizzo, Angela Dalia Ricci, Antonio Cusmai, Silvana Acquafredda, Giuseppe De Palma, Giovanni Brandi, Gennaro Palmiotti

Get full text